Markets

Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 11, 2018

Abbott Laboratories ( ABT ) will begin trading ex-dividend on January 11, 2018. A cash dividend payment of $0.28 per share is scheduled to be paid on February 15, 2018. Shareholders who purchased ABT prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 5.66% increase over prior dividend payment.

The previous trading day's last sale of ABT was $58.92, representing a -1.14% decrease from the 52 week high of $59.60 and a 50.11% increase over the 52 week low of $39.25.

ABT is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and TiGenix ( TIG ). ABT's current earnings per share, an indicator of a company's profitability, is $1.27. Zacks Investment Research reports ABT's forecasted earnings growth in 2017 as 13.5%, compared to an industry average of 11.9%.

For more information on the declaration, record and payment dates, visit the ABT Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.

Interested in gaining exposure to ABT through an Exchange Traded Fund [ETF]?

The following ETF(s) have ABT as a top-10 holding:

  • First Trust Nasdaq Pharmaceuticals ETF ( FTXH )
  • iShares U.S. Healthcare ETF ( IYH )
  • Vanguard Health Care ETF ( VHT )
  • Vanguard Div Appreciation ETF ( VIG )
  • AdvisorShares Vice ETF ( ACT ).

The top-performing ETF of this group is VIG with an increase of 11.59% over the last 100 days. FTXH has the highest percent weighting of ABT at 8.4%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

IYH VHT VIG JNJ FTXH ACT ABT

Other Topics

Stocks